Mamoura Diversified Global Holding in NxStage Medical, Inc.
Completed. First disclosed February 4, 2015, in a Schedule 13G/A (source).
- Investor
- Mamoura Diversified Global Holding (United Arab Emirates)
- Investor as named in source
- Mubadala Development Co PJSC (filer name at the time)
- Parent
- Mubadala Investment Company
- Target
- NxStage Medical, Inc. (EDGAR CIK 1333170)
- Target country
- United States
- Sector
- Health and Life Sciences (SIC 3845)
- First disclosed
- February 4, 2015, Schedule 13G/A
- Amount
- Not stated
- Stake at first disclosure
- 4.40%
- Latest stated stake
- 4.40% (February 4, 2015)
Source Filings and Releases
| Date | Document | Stated stake | Link |
|---|---|---|---|
| February 4, 2015 | Schedule 13G/A | 4.40% | View |
Cite: Middle East Forum, “Mamoura Diversified Global Holding in NxStage Medical, Inc.,” Gulf Sovereign Holdings, accessed October 13, 2026, https://statemoney.meforum.org/deal/mamoura-nxstage-medical-inc-1333170/.
Gulf money also reaches U.S. universities and lobbyists: the Influence Tracker holds Section 117 gift and contract disclosures and FARA registrations, and the Campus Watch Map places that funding on specific campuses.